Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14740590 | 0.84 | FTO (0.50) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL29452872 | 0.84 | FTO (0.50) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL418120 | 0.81 | MAPT (0.42) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL9810556 | 0.81 | FTO (0.48) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL29722 | 0.79 | CHRM3 (0.46) | MEN1KMT2ATDP1CYP2C19CYP2C9 | |
| SCHEMBL31085589 | 0.77 | FTO (0.44) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL9594691 | 0.77 | FTO (0.44) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL14022367 | 0.77 | HPGD (0.39) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL16200992 | 0.76 | FTO (0.43) | FTOHPGDMEN1KMT2ATDP1 | |
| SCHEMBL12939881 | 0.76 | FTO (0.50) | FTOHPGDMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076072-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2011-12-13 | — | — | US | claimed |
| US-8026057-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2011-09-27 | — | — | US | claimed |
| US-7468243-B2 | Nucleotide sequence labelling compoumd four use as tool in genetic engineering | AFFYMETRIX, INC. (US) | 2008-12-23 | — | — | US | claimed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | claimed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | claimed |
| US-11993772-B2 | Linking sequence reads using paired code tags | ILLUMINA, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20230406874-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | ILLUMINA, INC. | 2023-12-21 | — | — | US | disclosed |
| CN-116888143-A | Method for determining collagen content by using collagen hybrid peptide | 3螺旋有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-11760772-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20210277043-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | ILLUMINA, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| US-11021504-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-11008567-B2 | Oligonucleotide replacement for di-tagged and directional libraries | ILLUMINA, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| WO-1979000882-A1 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS | SYVA CO (US) | 1979-11-01 | — | — | WO | disclosed |
| US-4161515-A | DETECTING ANTILIGAND WITH LIGAND-ANALOG FLUORESCER | SYVA COMPANY (US) | 1979-07-17 | — | — | US | disclosed |
| US-4160016-A | Receptor fluorescent immunoassay | SYVA COMPANY (US) | 1979-07-03 | — | — | US | disclosed |
| US-4130462-A | Receptor steric hindrance immunoassay for receptor determination | SYVA COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-3998943-A | Double receptor fluorescent immunoassay | SYVA COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
| US-3996345-A | Fluorescence quenching with immunological pairs in immunoassays | SYVA COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
| US-3939350-A | Fluorescent immunoassay employing total reflection for activation | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1976-02-17 | — | — | US | disclosed |
| US-3935074-A | Antibody steric hindrance immunoassay with two antibodies | SYVA COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406874-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | PHAX, ALKBH1, JMJD6 | FTO 770/4885HPGD 4470/4885MEN1 2992/4885 |
| US-11021504-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | FTO 770/4885HPGD 4470/4885MEN1 2992/4885 |
| US-20210277043-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | PHAX, ALKBH1, JMJD6 | FTO 770/4885HPGD 4470/4885MEN1 2992/4885 |
| US-11760772-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | FTO 770/4885HPGD 4470/4885MEN1 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.